NOTICE IS HEREBY GIVEN that the 41st Annual General Meeting of the Members of ADS Diagnostic Limited will be held on Tuesday, the 29th September, 2026, at 11:30 A.M. Through Video Conferencing ....

HOLOGIC® THE SCIENCE OF SURE ADS/BSE/2026-27/07/09 04th September, 2026 The Listing Department Bombay Stock Exchange Limited Phiroze Jeejeebhoy Towers, 25th Floor, Dalal Street Mumbai, Maharashtra - 400001 SCRIP CODE: 523031 SUB- ANNUAL REPORT OF THE FORTY-FIRST (41ST) ANNUAL GENERAL MEETING FOR FY 2025-26 Dear Sir, Pursuant to the provision of Regulation 30 & 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) (as amended from time to time), please find enclosed herewith the copy of the Annual Report including the Business Responsibility & Sustainability Report for the Financial Year 2025-26 along with Notice of the 41st Annual General Meeting (“AGM”) scheduled on Tuesday, 29th September 2026 at 11.30 A.M.(IST) through Video Conferencing (“VC”)/ other Audio Visual Means (“OAVM”). Further, the aforesaid Annual Report along with the Notice of the AGM has also been uploaded on the website of the Company at www.adsdiagnosticlimited.com. Further, in accordance with the applicable circulars issued by MCA & SEBI, the Annual Report along with Notice of the AGM for the Financial Year 2025-26, is also being sent through electronic mode to those Members of the Company whose e-mail addresses are registered with the Company. Information at glance: Particulars Details Time and date of AGM Tuesday, 29th September,2026 at 11:30 A.M. IST Cut-off date for e-Voting Tuesday, 22nd September,2026 Remote e-Voting start time and date Saturday, 26th September, 2026 at 09:00 A.M. IST Remote e-Voting end time and date Monday, 28th September, 2026 at 05:00 P.M. IST Final dividend record date Sunday, 20th September, 2026 Thanking You, Yours Faithfully For ADS Diagnostic Limited N.L.Gayari CFO & Company Secretary ----------------------------------------------------------ADS DIAGNOSTIC LIMITED-------------------------------------------------------- 114 Sant Nagar East of Kailash New Delhi-110065 Tel -011-41620434, 41622193, FAX.: 011-41665880, : 07290037529, Email: adsmedical@rediffmail.com CIN-L85110DL1984PLC018486, Udyam Registration Number (MSME)- UDYAM-DL-08-0007361 ADS DIAGNOSTIC LIMITED ANNUAL REPORT 2025-2026 CONTENTS Page No. Corporate Information 01 Notice of 41st Annual General Meeting 02-09 Director's Report 10-20 Secretarial Audit Report 21-23 Statutory Reports 24-35 Dividend Distribution Policy Financial Statements 36-81 KEY INFORMATION BOARD COMPOSITION  Dr. Gautam Sehgal, Managing Director  Dr. (Mrs.) Versha Sehgal, Director  Dr. Vivek Sehgal, Director  Mrs. Radhika Sehgal, Director  Mr. Sunil Jasuja , Independent Director  Mr. Girish Sareen, Independent Director  Mr. Abhay Singh, Independent Director  Mr. Uday Walia, Independent Director  Mr. N.L. Gayari, CFO & Company Secretary STATUTORY AUDITOR  V.N PUROHIT & CO, Chartered Accountants. BANKERS  Bank of lndia, D-142, East of Kailash, New Delhi -110065. INTERNAL AUDITOR  V. K. Verma & Co. Chartered Accountants. SECRETE RIAL AUDITOR  Nitesh Singh & Associates Company Secretaries NOTICE NOTICE IS HEREBY GIVEN that the 41st Annual General Meeting of the Members of A D S DIAGNOSTIC LIMITED will be held on Tuesday, the 29th September, 2026, at 11:30 A.M. Through Video Conferencing (‘VC’)/ other Audio Visual means (‘OAVM’) facility to transact the following business: ORDINARY BUSINESS 1. To receive, consider and adopt the Audited Financial Statement of the Company for the year ended 31, March, 2026, together with the Reports of the Board of Directors and the Auditors thereon. 2. To appoint a Director in place of Dr. Radhika Sehgal (DIN: 00034317), who retires by rotation and, being eligible, offers Himself for re-appointment. 3. To declare Dividend on equity shares for the financial year 2025-26. 4. To consider and if thought fit to pass with or with or without modification(s) the following resolution as an Ordinary Resolution: “RESOLVED THAT pursuant to the provisions of Section 139 and all other applicable provisions, if any, of the Companies Act, 2013 and the Rules framed there under, as amended from time to time, the company hereby ratifies the appointment of M/s. V. N. Purohit & Co., Chartered Accountants (Registration No. 304040E), as Auditors of the Company to hold office from the conclusion of this Annual General Meeting (AGM) till the conclusion of the Next AGM of the Company to be held in the year 2027. SPECIAL BUSINESS RE-APPOINTMENT OF INDEPENDENT DIRECTORS: 5. To consider and if thought fit, to pass with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 and other applicable provisions, if any, of the Companies Act, 2013 read with Schedule IV to the Act and the Companies (Appointment and Qualification of Directors) Rules, 2014 (including any statutory modification(s) or re-enactment thereof for the time being in force) and Regulation 17 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and on the recommendation of the Nomination and Remuneration Committee and the Board of Directors, the consent of the Members of the Company be and is hereby accorded for the re- appointment of Mr. Girish Sareen (DIN: 00937770), who holds office as an Independent Director of the Company up to the conclusion of this Annual General Meeting and who is eligible for re-appointment and in respect of whom the Company has received a notice in writing under Section 160 of the Companies Act, 2013 proposing his candidature for the office of Director and who has submitted a declaration confirming that he meets the criteria of independence as provided under Section 149(6) of the Companies Act, 2013 and Regulation 16(1)(b) of the SEBI Listing Regulations, be and is hereby re-appointed as an Independent Director of the Company, not liable to retire by rotation, for a further term of one (1) consecutive years with effect from 29th September, 2026 up to 28th September, 2027. FURTHER RESOLVED THAT the Board of Directors of the Company be and is hereby authorised to do all such acts, deeds, matters and things as may be considered necessary, desirable or expedient to give effect to this resolution.” 6. To consider and if thought fit, to pass with or without modification(s), the following resolution as a Special Resolution: “RESOLVED THAT pursuant to the provisions of Sections 149, 150, 152 and other applicable provisions, if any, of the Companies Act, 2013 read with Schedule IV to the Act and the Companies (Appointment and Qualification of Directors) Rules, 2014 (including any statutory modification(s) or re-enactment thereof for the time being in force) and Regulation 17 and other applicable Regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and on the recommendation of the Nomination and Remuneration Committee and the Board of Directors, the consent of the Members of the Company be and is hereby accorded for the re- appointment of Mr. Sunil Jasuja (DIN: 01128112), who holds office as an Independent Director of the Company up to the conclusion of this Annual General Meeting and who is eligible for re-appointment and in respect of whom the Company has received a notice in writing under Section 160 of the Companies Act, 2013 proposing his candidature for the office of Director and who has submitted a declaration confirming that he meets the criteria of independence as provided under Section 149(6) of the Companies Act, 2013 and Regulation 16(1)(b) of the SEBI Listing Regulations, be and is hereby re-appointed as an Independent Director of the Company, not liable to retire by rotation, for a further term of one (1) consecutive years with effect from 29th September, 2026 up to 28th September, 2027. FURTHER RESOLVED THAT the Board of Directors of the Company be and is hereby authorised to do all such acts, deeds, matters and things as may be considered necessary, desirable or exp [Showing first 8,000 characters — download PDF for full document]